Pharmaceutical Microbiology USA

Drawing on from the huge success of SMi’s Pharmaceutical Microbiology UK events, SMi is delighted to announce the launch of Pharmaceutical Microbiology USA. The seventh in its series, this event will take place in San Diego, on the 8^th and 9^th June 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology USA 2017 will address the current challenges and developing trends of the pharmaceutical microbiology field.

Through a series of presentations from handpicked industry experts, two pre-conference workshops and an additional interactive training session, the agenda will discuss hot topics such as rapid microbiology methods (RMM), risk assessment, challenges in endotoxin recovery, environmental monitoring, sterility assurance, data integrity and much more…

Chairs for 2017:

• Donald Singer, GSK Fellow, Steriles Microbiology, R&D, GSK
   
• John Duguid, Senior Director, Research & Development, Vericel Corporation

Expert Speaker Line-Up Includes:

• Ron Smith, Director, External Supply Integration Quality, Janssen
   
• Ren-Yo Forng, Scientific Director, Amgen
   
• Kevin Luongo, QC Sr. Scientist (Microbiology), Takeda
   
• Elizabeth Hulanick, Microbiologist, Renaissance Pharmaceuticals
   
• Paul Ricciatti, Sterility Assurance Manager, Bimeda
   
• Jeanne Moldenhauer, Vice President, Excellent Pharma Consulting
   
• Akua Gilbert-Arthur, Principal Scientist, Roche Molecular Systems
   
• And many more…

Exclusive highlights in 2017: 

• Discuss the challenges involved with microbial control with Takeda
   
• Following the path to efficient sterility assurance with GSK
   
• Bimeda highlight the importance of environmental modelling
   
• Delve into the latest developments in rapid microbial methods with Janssen
   
• Hear the latest on data integrity and compliance with Roche
   
• Take part in an interactive extended training session with Microrite